BNTX BioNTech SE
Healthcare$92.25+0.12%ClosedMarket Cap: $23.33B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$135.10
Target (Median)
$139.00
Target Range
$96.00 - $158.00
Upside from current price: 46.4%
Rating Distribution
1 Strong Buy13 Buy6 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-06 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-05-06 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-27 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-10 | Morgan Stanley | maintain | Overweight | Overweight |
| 2026-03-11 | Citigroup | maintain | Buy | Buy |
| 2026-03-11 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-03-11 | TD Cowen | maintain | Hold | Hold |
| 2026-03-11 | BMO Capital | maintain | Outperform | Outperform |
| 2026-03-10 | Jefferies | maintain | Buy | Buy |
| 2026-01-16 | Goldman Sachs | upgrade | Buy | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-4.82 | $2.24B | 10 |
| Sun Dec 31 | $-4.06 | $2.63B | 13 |
| Mon Dec 31 | $-3.64 | $2.68B | 11 |
| Tue Dec 31 | $-1.32 | $3.39B | 5 |